Not all immunotherapies are created equal.

In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, compares TILs (Tumor-Infiltrating Lymphocytes) with AAIT (Autologous Adoptive Immunotherapy) — two powerful immune-based approaches designed to help the body fight cancer.

While TILs are extracted from the tumor and reactivated before being reinfused, AAIT starts with fresh, healthy natural killer (NK) cells and dendritic cells taken from the blood. These are trained using danger signals (DAMPs) and tumor antigens to recognize and destroy cancer cells more effectively.

🎯 What You’ll Learn in This Episode:

• The difference between TILs and AAIT in mechanism and safety
• Why TIL therapy often causes immune exhaustion and side effects
• How AAIT uses dendritic cells and DAMPs to “teach” the immune system
• Why NK cells can cross the blood-brain barrier and attack hidden tumors
• How making “cold” tumors “hot” improves immunotherapy results
• Why Envita focuses on immune retraining rather than single-shot therapy

📊 Dr. Prato explains how fresh, personalized immune cell therapies may help patients avoid the severe reactions sometimes seen with TILs while maintaining strong, targeted immune function.

“Your immune system is your army — the key is training it to win.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Is the cure worth the treatment?

In this episode of OutSmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, explores one of the toughest questions in oncology — why so many cancer treatments are harder on the body than the disease itself. He explains how maximum-dose chemotherapy can damage the immune system, cause painful side effects, and even drive resistance — while precision microdosing targets cancer more effectively with far less toxicity.

Using genetic mapping (DNA and RNA sequencing), spatial biology, and immune profiling, Dr. Prato shows how to match the right drug, dose, and delivery method to each patient’s unique cancer. From CIPI (Chemo-Immuno-Precision Injection) that delivers therapy directly into the tumor to immune-based cell treatments (AAIT) that train your own NK and dendritic cells to fight back — this is the next evolution of cancer care.

🎯 What You’ll Learn in This Episode:

• Why high-dose chemotherapy often does more harm than good
• How microdosed chemo (10%) kills tumors while sparing the immune system
• How interventional oncology delivers 100% of medicine directly to the tumor
• Why immune retraining with NK and dendritic cells improves long-term outcomes
• How detoxification and nutrition support immune recovery
• Why precision targeting led to 35x better responses and 43x better quality of life in published results*

*(See Outcomes Disclaimer Below)

“You don’t have to choose between treatment and quality of life — with precision, you can have both.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Will cancer ever be cured — or are we just managing symptoms?

In this visionary episode, Dr. Dino Prato, founder of Envita Medical Centers, explores whether cancer can disappear — not just through early detection or conventional care, but by addressing root causes and using thousands of biological data points to map precise, targeted treatment plans.

🎯 What You’ll Learn:

• Why standard cancer care often uses just 24 data points to guide treatment
• How precision oncology uses DNA, RNA, immune profiling & spatial biology
• The connection between mitochondrial dysfunction, infections, toxins, and cancer
• How liquid biopsy and non-invasive detection may stop cancer early — or before it starts
• Why many standard treatments create resistance, and what alternatives offer fewer side effects
• How to track remission using circulating tumor DNA (ctDNA) and methylation scores — not just scans

📊 According to Envita’s 2024 published data, patients treated with precision targeting showed 35x better outcomes, 43x improved quality of life, and 95x fewer side effects compared to historical norms.*
*(See Outcomes Disclaimer Below)

“Cancer may be complex — but it’s not unbeatable when your plan is precise.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

If your cancer treatment has failed — it doesn’t mean you’ve run out of hope.

In this deeply personal message, Dr. Dino Prato, founder of Envita Medical Centers, shares what happens when patients hit the end of the conventional oncology road. Many are told to go home, that no more can be done. But at Envita, we’ve helped thousands find personalized, precision-guided paths forward.

📊 In a 2024 study, our care model showed:

• 35x better clinical outcomes in late-stage cancer*

• 43x better quality of life*

• 95x fewer side effects, using advanced targeting and integrative support*
(*see outcomes disclaimer below)

🎯 What You’ll Learn:

• Why most patients we see were given the wrong chemo or integrative agents
• How precision testing (genomics, transcriptomics, immune profiling, spatial biology) opens new options
• Why mapping over 1,000 unique biomarkers can reveal treatments others miss
• Real-world case: A patient sent home from a major hospital entered remission with targeted care
• What you can do right now to stop the guesswork and start a new plan
• If you’re standing at a crossroads — unsure, exhausted, or afraid — you don’t have to do this alone. We’re here to guide you through next steps.

“You’re not out of options. You just haven’t been mapped correctly yet.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Think only the wealthy can afford personalized cancer treatment? Think again.

In this powerful episode, Dr. Dino Prato, founder of Envita Medical Centers, exposes the true cost of cancer care — not just in dollars, but in missed outcomes. From FDA fast-tracked drugs with minimal survival benefit to hospital and PBM markups that can reach 600%, he breaks down the economics of the cancer industry and compares them with precision-based care at Envita.

🎯 What You’ll Learn:

• Why most approved cancer drugs add just 3–5 months of life on average
• How pharmacy benefit managers (PBMs) and hospitals inflate drug costs by hundreds of percent
• Real-world examples of patients who paid 70–80% less and saw tumor clearance after 12 weeks
• What “N-of-1” precision medicine means: RNA, DNA, immune profiling, and spatial biology — built just for you
• How employers and health-sharing models are using Envita’s model to lower costs and improve care access

📊 In our clinical experience, this model showed 35x better outcomes, 43x better quality of life, and 95x fewer side effects — all at significantly lower cost.*
(*See Outcomes Disclaimer below)

"You can’t afford the wrong treatment. But the right one may cost less than you think.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Just diagnosed with cancer? Slow down — the most powerful thing you can do right now… is be still.

In this deeply compassionate episode, Dr. Dino Prato, founder of Envita Medical Centers, shares the first step every patient should take after hearing the words “you have cancer.” When fear is high and time feels short, the urge to rush into treatment is strong — but reactive medicine often leads to poor results.

🎯 What You’ll Learn:

• Why mapping your cancer before treatment may lead to better outcomes
• How genomic, immune, and infection-based testing changes the game
• The role of faith, prayer, and peace of mind in your healing process
• Why most patients we see have already tried the wrong treatments — simply because they weren’t targeted
• How our published outcomes show 35x better response and 43x better quality of life using precision cancer care*

(*See Outcomes Disclaimer Below)

If you're newly diagnosed or feel lost in a sea of opinions, this video will guide you toward clarity, calm, and confidence — all through data, faith, and personalized planning.

“You don’t have to follow the crowd. You need a map — and the strength to walk your path.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

The success of any cancer treatment hinges on identifying the right molecular targets. Improved patient outcomes can be achieved through precision medicine. Biomarker testing guides targeted therapy in oncology, improving cancer care.

“What are my chances with this cancer?” is the wrong question. Here's what to ask instead.

In this eye-opening episode, Dr. Dino Prato, founder of Envita Medical Centers, explains why traditional and integrative cancer treatments often fail — and how precision-targeted care can completely upgrade and improve outcomes as seen in the published literature and clinical experience.

Patients from around the world come to Envita after being told there are “no more options.” What makes the difference? Targets. Not just type and stage — but real-time, molecular-level precision.

🎯 What You’ll Learn:

• Why averages and general protocols can mislead your care
• How genomic testing and immune profiling uncover the real drivers of cancer
• What biomarkers, transcriptomics, and spatial biology mean for your remission
• How to ask the 10 essential questions to assess your treatment plan

Dr. Prato introduces a smarter path to healing — built on data over dogma.

✅ Get Dr. Prato's FREE Pocket Checklist:

https://assets.ctfassets.net/7k9stkq2d5ky/5qDyGiwCkrfaJkeA6sy9QF/3fa18f2a2240cf6d43eff9fabe00c9bc/physician-question-checklist.pdf

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Why do so many cancers resist treatment — even when patients receive the strongest chemotherapy available?

In this episode, Dr. Dino Prato, founder of Envita Medical Centers, explains the “Great Wall of Cancer”: a fibrous stromal barrier that surrounds many tumors. This wall blocks chemotherapy, immunotherapy, and even the body’s own immune system from reaching the cancer.

Dr. Prato discusses how this barrier forms, why it accelerates metastasis in cancers like pancreatic, breast, stomach, colorectal, and head and neck cancers, and how Envita uses advanced testing to identify and measure it.

🎯 What You’ll Learn in This Episode:

• Why IV chemotherapy often delivers less than 5% of the drug to the tumor
• How stromal barriers weaken immune cells and push cancer to spread
• The role of spatial biology, molecular profiling, and precision testing in mapping tumor defenses
• How interventional radiology delivers medicine directly inside tumors using tiny catheters
• Why CIPI (Chemo-Immuno-Precision Injection) improves outcomes and activates the immune system
• A real case study where stage IV neuroendocrine carcinoma was successfully treated with this method

📊 In published outcomes, patients receiving these precision approaches saw significant improvements in survival and quality of life compared to standard treatments.*
*(See Outcomes Disclaimer Below)

“Cancer may build a wall — but precision oncology helps break it down.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493